Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat
Aline Pic‐Taylor, Luciana Gueiros da Motta, Juliana Alves de Morais, et al.
Behavioural Processes (2015) Vol. 118, pp. 102-110
Closed Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes, Dayanna Barreto, Heloisa Onias, et al.
Psychological Medicine (2018) Vol. 49, Iss. 4, pp. 655-663
Open Access | Times Cited: 663
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos, Flávia de Lima Osório, José Alexandre S. Crippa, et al.
Therapeutic Advances in Psychopharmacology (2016) Vol. 6, Iss. 3, pp. 193-213
Open Access | Times Cited: 274
Neuropharmacology of N,N-dimethyltryptamine
Theresa M. Carbonaro, Michael B. Gatch
Brain Research Bulletin (2016) Vol. 126, pp. 74-88
Open Access | Times Cited: 204
Ayahuasca: Pharmacology, neuroscience and therapeutic potential
Elisabet Domínguez‐Clavé, Joaquim Soler, Matilde Elices, et al.
Brain Research Bulletin (2016) Vol. 126, pp. 89-101
Closed Access | Times Cited: 181
The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro
José Á. Morales-García, Mario de la Fuente Revenga, Sandra Alonso‐Gil, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 152
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
Jonathan Hamill, Jaime E. C. Hallak, Serdar Dursun, et al.
Current Neuropharmacology (2018) Vol. 17, Iss. 2, pp. 108-128
Open Access | Times Cited: 144
N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
Steven A. Barker
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 137
Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Lindsay P. Cameron, Charlie J. Benson, Lee E. Dunlap, et al.
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 7, pp. 1582-1590
Open Access | Times Cited: 133
The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging
Rafael G. dos Santos, Fermanda M Balthazar, José Carlos Bouso, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1230-1247
Closed Access | Times Cited: 112
Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms
Rafael G. dos Santos, Jaime E. C. Hallak
Neuroscience & Biobehavioral Reviews (2019) Vol. 108, pp. 423-434
Closed Access | Times Cited: 109
Classical hallucinogens and neuroimaging: A systematic review of human studies
Rafael G. dos Santos, Flávia de Lima Osório, José Alexandre S. Crippa, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 71, pp. 715-728
Closed Access | Times Cited: 95
Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
Ana Cecília de Menezes Galvão, Raíssa Nóbrega de Almeida, Erick Allan dos Santos Silva, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 89
Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT)
Lindsay P. Cameron, David E. Olson
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 10, pp. 2344-2357
Closed Access | Times Cited: 89
Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact
Andreia Machado Brito-da-Costa, Diana Dias da Silva, Nelson G. M. Gomes, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 11, pp. 334-334
Open Access | Times Cited: 86
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
Andrea Mastinu, Margrate Anyanwu, Marinella Carone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1329-1329
Open Access | Times Cited: 36
Ayahuasca‐enhanced extinction of fear behaviour: Role of infralimbic cortex 5‐HT2A and 5‐HT1A receptors
Isabel Werle, Laura Maria Martins Nascimento, A. Santos, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 11, pp. 1671-1689
Closed Access | Times Cited: 14
Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease
Albert Katchborian‐Neto, Wanderleya T. Santos, Karen de Jesus Nicácio, et al.
Journal of Ethnopharmacology (2020) Vol. 255, pp. 112743-112743
Open Access | Times Cited: 52
Ayahuasca's therapeutic potential: What we know – and what not
Lucas Oliveira Maia, Dimitri Daldegan‐Bueno, Isabel Wießner, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 45-61
Closed Access | Times Cited: 28
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease
Michael Tagen, Daniel Mantuani, Liron van Heerden, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 9, pp. 876-890
Closed Access | Times Cited: 20
Cardiovascular safety of psychedelic medicine: current status and future directions
Agnieszka Wsół
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1362-1380
Open Access | Times Cited: 20
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat
Oskar Hougaard Jefsen, Kristoffer Højgaard, Sofie Laage Christiansen, et al.
Acta Neuropsychiatrica (2019) Vol. 31, Iss. 04, pp. 213-219
Open Access | Times Cited: 53
Targeting cell cycle by β-carboline alkaloids in vitro: Novel therapeutic prospects for the treatment of cancer
Imad Ahmad, Sajad Fakhri, Haroon Khan, et al.
Chemico-Biological Interactions (2020) Vol. 330, pp. 109229-109229
Closed Access | Times Cited: 48
Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats
Camila Schoueri Colaço, Stefany Sousa Alves, Luciana Marangni Nolli, et al.
Metabolic Brain Disease (2020) Vol. 35, Iss. 5, pp. 739-751
Closed Access | Times Cited: 48
Ayahuasca: Uses, Phytochemical and Biological Activities
Edgar Antonio Estrella-Parra, Julio César Almanza-Pérez, Francisco Javier Alarcón-Aguilar
Natural Products and Bioprospecting (2019) Vol. 9, Iss. 4, pp. 251-265
Open Access | Times Cited: 47
Ayahuasca: A review of historical, pharmacological, and therapeutic aspects
Simon Ruffell, Max Crosland‐Wood, Rob Palmer, et al.
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top